Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Endometrial Cancer
100%
Mammalian Target of Rapamycin (mTOR)
100%
Nuclear Receptor 4A1
100%
Bisindole
30%
Cell Growth
20%
Growth Factors
20%
Endometrial Cells
20%
Endometrial Cancer Cells
20%
Endometrial Tumor
20%
Survival Genes
20%
Solid Tumors
10%
Tumor Growth in Vivo
10%
Decreased Expression
10%
Western Blot Analysis
10%
Xenograft
10%
MTOR Inhibitor
10%
Oncogenic Activity
10%
Associated Genes
10%
Knockdown
10%
Tumor Growth
10%
RNA Interference
10%
Cell number
10%
Gene Products
10%
Cell Survival
10%
Athymic nude Mice
10%
Ishikawa
10%
Whole Cell Lysate
10%
Functional Role
10%
Novel Therapeutic Targets
10%
Apoptotic Genes
10%
Annexin V Staining
10%
Cell Effects
10%
Gene Inhibition
10%
Pro-oncogenic
10%
Medicine and Dentistry
Cell Nucleus Receptor
100%
Uterine Cancer
100%
Reactive Oxygen Species
100%
mTOR Signaling
100%
Mammalian Target of Rapamycin
20%
Tumor Progression
20%
Cancer Cell
20%
Cell Growth
20%
Endometrium Tumor
20%
Solid Malignant Neoplasm
10%
In Vitro
10%
Receptor
10%
Western Blot
10%
Xenograft
10%
RNAI
10%
Gene Product
10%
Whole Cell
10%
Cell Survival
10%
Lipocortin 5
10%
Oncogenic activity
10%
Pharmacology, Toxicology and Pharmaceutical Science
Endometrium Cancer
100%
Cell Nucleus Receptor
100%
Indole
30%
Tumor Growth
20%
Endometrium Tumor
20%
Solid Malignant Neoplasm
10%
Nude Mouse
10%
Western Blot
10%
Receptor
10%
Lipocortin 5
10%
Oncogenic activity
10%